What Caused This Marijuana Stock to Soar 27% in February?

By:
What Caused This Marijuana Stock to Soar 27% in February?

Pixabay / RaphaelaFotografie / CC0 Public Domain

What happened

After management announced a compassionate-use program so that patients could continue getting its cannabidiol epilepsy drug, Insys Therapeutics’ (NASDAQ:INSY) shares shot 27% higher in February, according to S&P Global Market Intelligence.

So what

Insys Therapeutics has been struggling to overcome backlash stemming from allegations and the arrest of former executives who have been accused for illegally marketing the company’s opioid pain medicine, Subsys.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top